Investors didn't show much interest in one Climb Bio way or another today. It hasn't moved too much today but is slightly down, it lost -0.39% since yesterday.
Currently CLYM isn't at a clear support/resistance line that seems tradable. But let's also consider momentum! Climb Bio has had a nice run over the last year and provided good returns to shareholders. Over the previous year, the asset has grown 782.07 percent which isn't too bad. It may find some support around the $11.96 price level in the near term.